Quotes

Back To Menu

Tata India Pharma & Healthcare Fund (G) Equity - Pharma

INVEST

Plan: OPEN | Option: Growth | Rajat Srivastava

27 Jan 26 | 12:00 AM

28.59 -0.04 (-0.16%)

  • Underperforms

    -0.62%

    Return (1Y)

    underperformed BSE Healthcare TRI by -48.94%

  • More Volatile

    0.85%

    Standard Deviation (1Y)

    Higher Equity - Pharma by 0.85%

  • Inconsistent

    /0

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • Tata India Pharma & Healthcare Fund (G) fund has been the 10th best in 5Y performance in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been given the 9th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been the 10th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (G), has underperformed by -48.94% (CAGR difference)

-0.62%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

29 Jan 2025

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (G) is Higher than by 0.85%

0.85%

More Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For out of Last 0 Months, i.e 0% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition